Corporate calendar for Delcath Systems, Inc. (DCTH): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investigational product is the HEPZATO KIT, a unique hepatic delivery system for melphalan that targets high-dose chemotherapy specifically to the liver. This innovative approach aims to substantially reduce systemic drug exposure and mitigate associated side effects.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | $159M | |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | ||
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 |
Stock Splits
| Date | Ratio |
|---|---|
| 2019-12-24 | 1:700 |
| 2019-10-22 | 1:100 |
| 2018-05-02 | 1:500 |
| 2017-11-06 | 1:350 |
| 2016-07-21 | 1:16 |
| 2014-04-09 | 1:16 |
Price
| Price | $16.22 |
| Market Cap | $560M |
| Exchange | NASDAQ |
| Country | US |
Related companies: AGL · BWAY · CERS · MASS · NAKA · NPCE · RXST
Explore sector: Healthcare · Medical - Devices
More sections of DCTH: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks